Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACVBP Followed by ASCT in BCL-2+ DLBCL
NCT00169130Phase 3Completed
- Sponsor
- Lymphoma Study Association
- Start
- Oct 1999
- Modality
- DNA Intercalators/Alkylators, Stem Cell Therapies, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone in diffuse large B-cell lymphoma (DLBCL), sponsored by Lymphoma Study Association. Started Oct 1999; status: completed.
02
Drugs
doxorubicincyclophosphamidevindesinebleomycinprednisone
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00169130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169130.